Tamarack Biotics announces EU approval for TruActive products
The approval covers all ultraviolet treated TruActive products, including TruActive MPC 85, TruActive WPI 90, and TruActive LTF, a lactoferrin product.
“TruActive products utilize proprietary UV treatment and low temperature drying processes that retain more of raw milk’s immune active proteins and enzymes than any other product available today,” said Bob Comstock, CEO of Tamarack Biotics.
“These immune active proteins offer health benefits to everyone, but particularly young children, sports enthusiasts, and the elderly.”
Tamarack is currently negotiating with potential European production partners and hopes to offer samples by the end of the year.
A University of California Davis-led clinical trial showed TruActive restored immune function in an elderly population. The company said raw milk proteins positively impact gut health, and the non-denatured proteins have significantly higher bioavailability. Additionally, the company said the taste, smell, and dissolution are far superior to existing thermally pasteurized products.
Tamarack said it also plans to test TruActive’s ability to reduce allergy development in children.